Literature DB >> 12626417

Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans.

Ryo Misaki1, Yoshinobu Kimura, Nirianne Q Palacpac, Shohei Yoshida, Kazuhito Fujiyama, Tatsuji Seki.   

Abstract

Previously, we generated transgenic tobacco BY2 suspension-cultured cells (GT6 cells) that produced human beta1,4-galactosyltransferase. In this study, we analyze the N-glycan structures of glycoproteins secreted from GT6 cells to the spent medium. The N-glycans were liberated by hydrazinolysis, and the resulting oligosaccharides were labeled with 2-aminopyridine (PA). The pyridylaminated glycans were purified by reversed-phase and size-fractionation HPLC. The structures of the PA sugar chains were identified by the combined use of 2D PA sugar chain mapping, MS/MS analysis, and exoglycosidase digestion. The distribution of proposed N-glycan structures of GT6-secreted glycoproteins (GalGNM5 [26.8%], GalGNM4 [18.4%], GalGNM3 [19.6%], and GalGNM3X [35.2%]) is different from that found in intracellular glycoproteins (M7A [9.3%], M7B [15.9%], M6B [19.5%], M5 [1.4%], M3X [6.6%], GalGNM5 [35.5%], and GalGNM3 [11.8%]). In vitro, sialic acid was transferred to sugar chains of extracellular glycoproteins from the GT6 spent medium. The results suggest that sugar chains of extracellular glycoproteins from the GT6 spent medium are candidates for substrates of sialic acid transfer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12626417     DOI: 10.1093/glycob/cwg021

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Glyco-Engineering of Plant-Based Expression Systems.

Authors:  Rainer Fischer; Tanja Holland; Markus Sack; Stefan Schillberg; Eva Stoger; Richard M Twyman; Johannes F Buyel
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

2.  N-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human β-1,4-galactosyltransferase.

Authors:  Catherine Navarre; Nicolas Smargiasso; Laurent Duvivier; Joseph Nader; Johann Far; Edwin De Pauw; Marc Boutry
Journal:  Transgenic Res       Date:  2017-03-22       Impact factor: 2.788

3.  Expression of natural human β1,4-GalT1 variants and of non-mammalian homologues in plants leads to differences in galactosylation of N-glycans.

Authors:  Thamara Hesselink; Gerard J A Rouwendal; Maurice G L Henquet; Dion E A Florack; Johannes P F G Helsper; Dirk Bosch
Journal:  Transgenic Res       Date:  2014-08-01       Impact factor: 2.788

Review 4.  Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.

Authors:  Susan A Brooks
Journal:  Mol Biotechnol       Date:  2004-11       Impact factor: 2.695

Review 5.  IgG-Fc glycoengineering in non-mammalian expression hosts.

Authors:  Andreas Loos; Herta Steinkellner
Journal:  Arch Biochem Biophys       Date:  2012-05-23       Impact factor: 4.013

6.  Characterization of the single-chain Fv-Fc antibody MBP10 produced in Arabidopsis alg3 mutant seeds.

Authors:  Maurice Henquet; Jochem Eigenhuijsen; Thamara Hesselink; Holger Spiegel; Mariëlle Schreuder; Esther van Duijn; Jan Cordewener; Ann Depicker; Alexander van der Krol; Dirk Bosch
Journal:  Transgenic Res       Date:  2010-12-25       Impact factor: 2.788

7.  Unexpected Arabinosylation after Humanization of Plant Protein N-Glycosylation.

Authors:  Lennard L Bohlender; Juliana Parsons; Sebastian N W Hoernstein; Nina Bangert; Fernando Rodríguez-Jahnke; Ralf Reski; Eva L Decker
Journal:  Front Bioeng Biotechnol       Date:  2022-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.